These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26016631)

  • 1. Aflibercept for the treatment of neovascular glaucoma.
    SooHoo JR; Seibold LK; Pantcheva MB; Kahook MY
    Clin Exp Ophthalmol; 2015 Dec; 43(9):803-7. PubMed ID: 26016631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study.
    Inatani M; Higashide T; Matsushita K; Nagasato D; Takagi H; Ueki M; Takai Y; Miyazaki K; Iwamoto Y; Kobayashi M; Leal S
    Adv Ther; 2021 Feb; 38(2):1106-1115. PubMed ID: 33330959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Aflibercept in Japanese Patients with Neovascular Glaucoma: The VEGA Randomized Clinical Trial.
    Inatani M; Higashide T; Matsushita K; Miki A; Ueki M; Iwamoto Y; Kobayashi M; Leal S;
    Adv Ther; 2021 Feb; 38(2):1116-1129. PubMed ID: 33330958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
    Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
    Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
    Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
    J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.
    Olmos LC; Sayed MS; Moraczewski AL; Gedde SJ; Rosenfeld PJ; Shi W; Feuer WJ; Lee RK
    Eye (Lond); 2016 Mar; 30(3):463-72. PubMed ID: 26681145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma--results from a prospective interventional case series.
    Lüke J; Nassar K; Lüke M; Grisanti S
    Graefes Arch Clin Exp Ophthalmol; 2013 Oct; 251(10):2403-13. PubMed ID: 23893090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization: The MYRROR Study.
    Ikuno Y; Ohno-Matsui K; Wong TY; Korobelnik JF; Vitti R; Li T; Stemper B; Asmus F; Zeitz O; Ishibashi T;
    Ophthalmology; 2015 Jun; 122(6):1220-7. PubMed ID: 25745875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study.
    Sasamoto Y; Oshima Y; Miki A; Wakabayashi T; Song D; Matsushita K; Hamasaki T; Nishida K
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):41-8. PubMed ID: 21992534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study.
    Shi L; Yang J; Lin J
    BMC Ophthalmol; 2019 Jun; 19(1):128. PubMed ID: 31185956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
    Duch S; Buchacra O; Milla E; Andreu D; Tellez J
    J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma.
    Nagendran ST; Finger PT
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):201-7. PubMed ID: 25707045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term.
    Sun Y; Liang Y; Zhou P; Wu H; Hou X; Ren Z; Li X; Zhao M
    BMC Ophthalmol; 2016 Aug; 16(1):150. PubMed ID: 27576739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical bevacizumab for neovascular glaucoma: a pilot study.
    Waisbourd M; Shemesh G; Kurtz S; Rachmiel R; Moisseiev E; Zayit-Soudri S; Loewenstein A; Barequet I
    Pharmacology; 2014; 93(3-4):108-12. PubMed ID: 24556733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular pressure in patients with neovascular age-related macular degeneration switched to aflibercept injection after previous anti-vascular endothelial growth factor treatments.
    Rusu IM; Deobhakta A; Yoon D; Lee M; Slakter JS; Klancnik JM; Thompson D; Freund KB
    Retina; 2014 Nov; 34(11):2161-6. PubMed ID: 25072648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
    Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
    J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up.
    Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
    Acta Ophthalmol; 2015 Feb; 93(1):e1-6. PubMed ID: 24989855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma.
    Wang JW; Zhou MW; Zhang X; Huang WB; Gao XB; Wang W; Chen S; Zhang XY; Ding XY; Jonas JB
    Clin Exp Ophthalmol; 2015 Jul; 43(5):415-21. PubMed ID: 25488632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.